Biologicals

Hepatitis

Hepatitis A vaccine

Title: Requirements for hepatitis A vaccines (inactivated); Adopted 1994, TRS No 858, Annex 2

Hepatitis B vaccines, DNA recombinant

Recommendations to Assure the Quality, Safety and Efficacy of Recombinant Hepatitis B Vaccines. Proposed replacement of: TRS 786, Annex 2 and TRS 889, Annex 4.

Hepatitis B vaccine, plasma

Hepatitis WHO Working Group on Hepatitis and HIV Diagnostic Kits

Expert Committee on Biological Standardization, Geneva, 17-21 November 2003

UPCOMING EVENTS


  • WHO Informal Consultation on Regulatory considerations for evaluation of Ebola Vaccines intended for emergency use, WHO/HQ Geneva, Switzerland, 18-19 March 2015
  • WHO Informal Consultation on Stability Evaluation of Vaccines for use in a Controlled Temperature Chain, WHO/HQ Geneva, Switzerland, 24–26 March 2015
  • WHO Informal Consultation on Amendment for Similar Biotherapeutic products of monoclonal antibodies, WHO/HQ Geneva, Switzerland, 27–28 April 2015
  • WHO Informal Consultation on Regulatory risk assessment for biotherapeutic products, WHO/HQ Geneva, Switzerland, 29–30 April 2015

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971